ESMO Stresses the Importance of Continuity of Cancer Clinical Trials (CT) During Public Health Emergencies (PHE) in Response to European Medicines Agency (EMA) Consultation

ESMO feedback to EMA public consultation on new guidance for the conduct of CTs during PHEs in the European Union underscores the critical importance of safeguarding the continuity of cancer CTs during times of crisis

Source